Caption Management, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,612,200
-24.6%
60,0000.0%0.02%
-36.8%
Q2 2023$2,139,600
+19.8%
60,000
-14.7%
0.04%
+8.6%
Q1 2023$1,785,620
-40.0%
70,300
-21.9%
0.04%
-16.7%
Q3 2022$2,974,000
-3.9%
90,000
+2.4%
0.04%
-2.3%
Q2 2022$3,095,000
-65.1%
87,900
-54.4%
0.04%
-59.4%
Q1 2022$8,872,000
+53.1%
192,934
+120.7%
0.11%
+63.1%
Q4 2021$5,796,000
+53.3%
87,400
+44.3%
0.06%
+47.7%
Q3 2021$3,781,000
-71.4%
60,556
-62.0%
0.04%
-74.6%
Q2 2021$13,209,000
+7.6%
159,500
-0.3%
0.17%
-38.0%
Q4 2020$12,278,000
+850.3%
160,000
+433.3%
0.28%
+830.0%
Q3 2020$1,292,000
-51.2%
30,000
-51.1%
0.03%
-65.9%
Q2 2020$2,647,000
+409.0%
61,302
+647.6%
0.09%
+417.6%
Q4 2019$520,000
-69.2%
8,200
-86.3%
0.02%
-80.7%
Q3 2019$1,690,000
-36.2%
60,000
-40.0%
0.09%
-33.8%
Q2 2019$2,649,000100,0000.13%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders